Estimate spontaneous passage rates by stone size and location, treatment options, prevention strategies, and 24-hour urine interpretation for kidney stones.
The Kidney Stone Calculator provides evidence-based estimates for spontaneous stone passage probability, expected passage time, treatment recommendations, and personalized prevention strategies based on stone size, location, and composition. Kidney stones affect approximately 1 in 11 people in the United States, with lifetime recurrence rates of 50-80% without prevention — making this one of the most commonly encountered urologic emergencies.
The critical clinical decision in acute stone management is whether to pursue observation with medical expulsive therapy (MET) or proceed to surgical intervention. This depends primarily on stone size and location: distal ureteral stones ≤6mm have approximately 60-95% spontaneous passage rates, while proximal stones >6mm rarely pass without intervention. Current AUA and EAU guidelines inform these recommendations, and this calculator maps your stone's characteristics to the appropriate management pathway.
Beyond acute management, this calculator analyzes stone composition and 24-hour urine metabolic data to generate personalized prevention strategies. With proper dietary and medical intervention, recurrence rates can be reduced from 50% to under 15% at 5 years — yet fewer than 10% of stone formers receive adequate metabolic evaluation. This tool bridges that gap by interpreting key urine chemistry values and generating targeted dietary recommendations.
Understanding stone passage probability guides the critical decision between watchful waiting and surgical intervention. This calculator provides evidence-based estimates to help patients and primary care providers make informed management decisions and initiate proper metabolic prevention workup. Keep these notes focused on your operational context. Tie the context to the calculator’s intended domain. Use this clarification to avoid ambiguous interpretation.
Spontaneous passage rates derived from meta-analyses: distal ureter <4mm: 76-95%, 4-6mm: 60%, >6mm: 35%. Proximal ureter rates are 20-30% lower. Medical expulsive therapy (tamsulosin) increases passage rates by ~30% for stones 5-10mm.
Result: 60% passage rate, expected 2-4 weeks with MET
A 5mm distal ureteral calcium oxalate stone has approximately 60% chance of spontaneous passage. Medical expulsive therapy with tamsulosin 0.4mg daily is recommended along with adequate hydration. NSAIDs (ketorolac, ibuprofen) for pain control.
**Calcium Oxalate (70-80%)**: The most common stone type, often with calcium phosphate core. Risk factors include hypercalciuria, hyperoxaluria, hypocitraturia, and low urine volume. Dietary management focuses on adequate calcium intake (1000-1200 mg/day — paradoxically, adequate calcium binds dietary oxalate in the gut), reduced sodium and animal protein, increased citrate, and avoidance of high-oxalate foods (spinach, nuts, chocolate). Thiazide diuretics reduce urinary calcium; potassium citrate increases urinary citrate.
**Uric Acid (5-10%)**: The only dissolution-eligible stone. Form in acidic urine (pH < 5.5) and are radiolucent on X-ray. Management: alkalinize urine to pH 6.0-6.5 with potassium citrate (20-30 mEq TID), increase fluids, reduce purine-rich foods. Allopurinol for hyperuricemia. Complete dissolution may take 2-6 months.
**Struvite (5-15%)**: Caused by urease-producing bacteria that split urea into ammonia, raising urine pH and creating magnesium ammonium phosphate crystals. Can form large "staghorn" calculi filling the renal pelvis. Treatment requires surgical removal plus targeted antibiotics. Acetohydroxamic acid (AHA) inhibits urease but has significant side effects.
**Cystine (1-2%)**: Autosomal recessive cystinuria causing excessive urinary cystine. Requires lifelong management: very high fluid intake (>3L/day, including nighttime waking), urine alkalinization to pH 7.0-7.5, sodium restriction, and potentially tiopronin or D-penicillamine for refractory cases.
The three main surgical options for kidney stones differ in their indications and effectiveness:
**ESWL** (Extracorporeal Shock Wave Lithotripsy): Non-invasive, outpatient. Best for renal stones ≤20mm and proximal ureteral stones. Stone-free rates 50-70%. Less effective for lower pole stones, hard stones (calcium oxalate monohydrate, cystine), obese patients, and stones >15mm. No incisions required.
**Ureteroscopy (URS)**: Flexible or semi-rigid scope with laser lithotripsy. Stone-free rates 80-95% for ureteral stones, 70-85% for renal stones. Can treat stones in any location. Requires anesthesia and possible stent placement. Gold standard for mid/distal ureteral stones.
**PCNL** (Percutaneous Nephrolithotomy): Most invasive but most effective for large renal stones (>20mm). Stone-free rates 85-95%. Requires percutaneous renal access, hospitalization, and carries higher complication risk. Indicated for staghorn calculi and large stone burdens.
Stones ≤4mm in the distal ureter pass spontaneously 76-95% of the time. Stones 5-6mm have about 60% passage rates with medical expulsive therapy. Stones >6mm in the ureter and >10mm in the kidney typically require intervention.
For stones 5-10mm, tamsulosin (an alpha-blocker that relaxes ureteral smooth muscle) increases passage rates by approximately 30% and reduces time to passage. For stones <5mm, the benefit is less clear. The landmark CaStONE trial showed benefit primarily for distal stones 5-10mm.
During acute colic, moderate hydration is recommended — excessive fluid loading can increase ureteral pressure and pain. For prevention, target 2.5-3L of fluid daily (enough to produce >2L of urine). Water is best; lemonade provides citrate; avoid sugar-sweetened beverages.
Non-contrast CT is the gold standard with 95-98% sensitivity. Ultrasound is preferred for pregnancy and pediatrics. CT also detects alternative diagnoses. KUB X-ray can follow known radiopaque stones but misses uric acid and small stones.
Seek emergency care for: fever with stone symptoms (infected obstructing stone is a urologic emergency), inability to keep fluids down, uncontrolled pain despite oral medications, a single kidney, or no urine output. Infected obstruction requires emergency ureteral stent or nephrostomy.
Yes — uric acid stones are the only common stone type that can be dissolved medically. Alkalinizing urine to pH 6.0-6.5 with potassium citrate dissolves existing stones over weeks to months and prevents new ones. This is one of the most satisfying treatments in urology.